GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Bachem Holding AG (OTCPK:BCHMF) » Definitions » Debt-to-Asset

Bachem Holding AG (Bachem Holding AG) Debt-to-Asset : 0.00 (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Bachem Holding AG Debt-to-Asset?

Bachem Holding AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.0 Mil. Bachem Holding AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.3 Mil. Bachem Holding AG's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was $1,946.0 Mil. Bachem Holding AG's debt to asset for the quarter that ended in Dec. 2023 was 0.00.


Bachem Holding AG Debt-to-Asset Historical Data

The historical data trend for Bachem Holding AG's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bachem Holding AG Debt-to-Asset Chart

Bachem Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.02 - -

Bachem Holding AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 - - - -

Competitive Comparison of Bachem Holding AG's Debt-to-Asset

For the Chemicals subindustry, Bachem Holding AG's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bachem Holding AG's Debt-to-Asset Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Bachem Holding AG's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Bachem Holding AG's Debt-to-Asset falls into.



Bachem Holding AG Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Bachem Holding AG's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Bachem Holding AG's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bachem Holding AG  (OTCPK:BCHMF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Bachem Holding AG Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Bachem Holding AG's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Bachem Holding AG (Bachem Holding AG) Business Description

Traded in Other Exchanges
Address
Hauptstrasse 144, Bubendorf, CHE, 4416
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients, as well as on the development of biochemical products for research purposes. The group markets its product under the Bachem and Clinalfa brands. The business of the firm can be seen booming across the market of Switzerland, USA, Austria, Great Britain, Germany and internationally and it generates revenue through the sale of the product.

Bachem Holding AG (Bachem Holding AG) Headlines

No Headlines